PTHS – pelthos therapeutics inc. (US:NASDAQ)

News

Pelthos Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
Pelthos Therapeutics Announces CFO Transition
Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain
Pelthos Therapeutics Maps Public-Market Path, ZELSUVMI Surge, Adds Xepi and Xeglyze in Roth Interview [Yahoo! Finance]
Pelthos Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com